{"id":"azasite","safety":{"commonSideEffects":[{"rate":null,"effect":"Eye irritation"},{"rate":null,"effect":"Conjunctival hyperemia"},{"rate":null,"effect":"Ocular discomfort"},{"rate":null,"effect":"Taste perversion"}]},"_chembl":null,"_dailymed":{"setId":"0c5d6f5e-18ea-436f-8c62-bbaf66effe3d","title":"AZASITE (AZITHROMYCIN MONOHYDRATE) SOLUTION/ DROPS [THEA PHARMA INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. In addition to direct antimicrobial activity, azithromycin has immunomodulatory properties that reduce inflammatory cytokines and mucin hypersecretion in ocular tissues, making it effective for both infectious and inflammatory ocular conditions.","oneSentence":"AzaSite is an azithromycin ophthalmic suspension that reduces bacterial load and inflammatory mediators in the eye to treat bacterial conjunctivitis and meibomian gland dysfunction.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:28:01.927Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial conjunctivitis"},{"name":"Meibomian gland dysfunction (dry eye disease)"}]},"trialDetails":[{"nctId":"NCT03656926","phase":"PHASE3","title":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-03-26","conditions":"Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection","enrollment":169},{"nctId":"NCT04677569","phase":"PHASE3","title":"Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex","status":"COMPLETED","sponsor":"Insmed Incorporated","startDate":"2021-04-01","conditions":"Mycobacterium Infections, Nontuberculous","enrollment":425},{"nctId":"NCT03657342","phase":"PHASE3","title":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-03-26","conditions":"Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection","enrollment":62},{"nctId":"NCT06584474","phase":"PHASE4","title":"THE EFFECT OF NEBULIZED AZITHROMYCIN AS THERAPY FOR BRONCHOPULMONARY DYSPLASIA","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-10-02","conditions":"Bronchopulmonary Dysplasia, Premature, Ventilation, Mechanical","enrollment":100},{"nctId":"NCT03162497","phase":"PHASE4","title":"Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland Dysfunction","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2018-01-08","conditions":"Dry Eye Syndromes, Meibomian Gland Dysfunction","enrollment":23},{"nctId":"NCT06325293","phase":"NA","title":"A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study","status":"RECRUITING","sponsor":"Christoph Berger","startDate":"2025-01-28","conditions":"Community Acquired Pneumonia in Children, Mycoplasma Pneumoniae, Mycoplasma Pneumoniae Pneumonia","enrollment":376},{"nctId":"NCT05812820","phase":"NA","title":"Effects of Probiotic in Treatment of Persistent Diarrhea in Children","status":"COMPLETED","sponsor":"National Children's Hospital, Vietnam","startDate":"2022-07-01","conditions":"Diarrhea","enrollment":165},{"nctId":"NCT00830336","phase":"PHASE1","title":"A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2005-10","conditions":"Healthy","enrollment":80},{"nctId":"NCT00830206","phase":"PHASE1","title":"A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2006-01","conditions":"Healthy","enrollment":80},{"nctId":"NCT00834756","phase":"PHASE1","title":"Azithromycin 600 Mg Tablets, Fasting","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-09","conditions":"Healthy","enrollment":36},{"nctId":"NCT00834132","phase":"PHASE1","title":"Azithromycin 600 Mg Tablets, Fed","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-07","conditions":"Healthy","enrollment":24},{"nctId":"NCT05027516","phase":"PHASE4","title":"Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2022-01-17","conditions":"Neisseria Gonorrhoeae","enrollment":42},{"nctId":"NCT04677543","phase":"PHASE3","title":"Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex","status":"COMPLETED","sponsor":"Insmed Incorporated","startDate":"2020-12-22","conditions":"Mycobacterium Infections, Nontuberculous","enrollment":99},{"nctId":"NCT00650273","phase":"PHASE1","title":"Fasting Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-04","conditions":"Healthy","enrollment":54},{"nctId":"NCT00649935","phase":"PHASE1","title":"Fed Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-05","conditions":"Healthy","enrollment":54},{"nctId":"NCT05634759","phase":"PHASE4","title":"Enhancing the A in SAFE for Trachoma","status":"COMPLETED","sponsor":"Emory University","startDate":"2022-05-04","conditions":"Trachoma","enrollment":34630},{"nctId":"NCT06149117","phase":"PHASE4","title":"Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China","status":"COMPLETED","sponsor":"Peking University People's Hospital","startDate":"2022-11-16","conditions":"Upper Respiratory Tract Infection, Lower Respiratory Infection, Skin Infection","enrollment":48},{"nctId":"NCT03676751","phase":"PHASE4","title":"MORDOR II Burkina Faso: Longitudinal Trial","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2019-10-10","conditions":"Child Growth, Diversity of Microbiome, Child Mortality","enrollment":500},{"nctId":"NCT04315272","phase":"PHASE4","title":"Gut and Azithromycin Mechanisms in Infants and Children II","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2020-08-21","conditions":"Malaria","enrollment":449},{"nctId":"NCT05465304","phase":"","title":"Effect of Azithromycin in Preventing Premature Labour","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2021-10-01","conditions":"Pregnant With Complication","enrollment":200},{"nctId":"NCT02336516","phase":"NA","title":"Azithromycin in Post Diarrheal Haemolytic and Uremic Syndrome","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-07","conditions":"Haemolytic and Uremic Syndrome","enrollment":148},{"nctId":"NCT04160026","phase":"PHASE4","title":"Acceptability and Feasibility in the Context of the IMPROVE Trial in Kenya","status":"COMPLETED","sponsor":"Liverpool School of Tropical Medicine","startDate":"2019-11-11","conditions":"Malaria in Pregnancy, Adherence, Treatment","enrollment":1600},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT04696003","phase":"PHASE3","title":"Treatment of Classic Mid-trimester PPROM by Means of Continuous Amnioinfusion","status":"UNKNOWN","sponsor":"Martin-Luther-Universität Halle-Wittenberg","startDate":"2021-01-01","conditions":"Bronchopulmonary Dysplasia, Necrotizing Enterocolitis, Intracranial Hemorrhages","enrollment":68},{"nctId":"NCT04361461","phase":"PHASE3","title":"Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)","status":"WITHDRAWN","sponsor":"Apsen Farmaceutica S.A.","startDate":"2020-04-30","conditions":"Coronavirus Infections, SARS-CoV 2, SARS (Severe Acute Respiratory Syndrome)","enrollment":""},{"nctId":"NCT04371406","phase":"PHASE3","title":"Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients","status":"WITHDRAWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-04","conditions":"Covid-19","enrollment":""},{"nctId":"NCT04558463","phase":"PHASE3","title":"The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2020-04-16","conditions":"Covid19","enrollment":100},{"nctId":"NCT04278937","phase":"PHASE4","title":"Antenatal Azithromycin to Prevent Preterm Birth in Pregnant Women With Vaginal Cerclage","status":"COMPLETED","sponsor":"Ain Shams Maternity Hospital","startDate":"2019-04-15","conditions":"Preterm Birth","enrollment":50},{"nctId":"NCT02205242","phase":"PHASE3","title":"BACE Trial Substudy 1 - PROactive Substudy","status":"COMPLETED","sponsor":"Wim Janssens","startDate":"2014-09","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":60},{"nctId":"NCT03278808","phase":"PHASE2","title":"Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis","status":"WITHDRAWN","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2018-09-17","conditions":"Malaria","enrollment":""},{"nctId":"NCT00035347","phase":"PHASE4","title":"Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia","status":"COMPLETED","sponsor":"Pfizer","startDate":"2001-01","conditions":"Community-Acquired Pneumonia (CAP)","enrollment":219},{"nctId":"NCT02726269","phase":"PHASE3","title":"Triple Therapy Versus Levofloxacin-based Therapy for Helicobacter Pylori Eradication in Mexico.","status":"COMPLETED","sponsor":"Asofarma de México S.A de C.V.","startDate":"2012-06","conditions":"Helicobacter Pylori Gastritis","enrollment":230},{"nctId":"NCT01915082","phase":"PHASE4","title":"Peri-operative Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2013-09","conditions":"Disorder Related to Lung Transplantation","enrollment":70},{"nctId":"NCT01089608","phase":"PHASE2","title":"Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis","status":"COMPLETED","sponsor":"Laboratoires Thea","startDate":"2010-03","conditions":"Blepharitis","enrollment":93},{"nctId":"NCT00682656","phase":"PHASE2, PHASE3","title":"Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis","status":"TERMINATED","sponsor":"Ana Rabello","startDate":"2008-06","conditions":"Cutaneous Leishmaniasis","enrollment":48},{"nctId":"NCT02171338","phase":"PHASE4","title":"Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections","status":"UNKNOWN","sponsor":"Holbaek Sygehus","startDate":"2013-10","conditions":"Pneumonia, Acute Exacerbation of Chronic Obstructive Airways Disease","enrollment":55},{"nctId":"NCT00105534","phase":"PHASE3","title":"Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-07","conditions":"Bacterial Conjunctivitis","enrollment":685},{"nctId":"NCT01102244","phase":"PHASE3","title":"A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2010-04","conditions":"Blepharitis","enrollment":122},{"nctId":"NCT00656539","phase":"PHASE4","title":"Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-04","conditions":"Blepharitis","enrollment":20},{"nctId":"NCT00629941","phase":"PHASE4","title":"Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-03","conditions":"Blepharitis","enrollment":25},{"nctId":"NCT00629980","phase":"PHASE4","title":"Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-02","conditions":"Blepharitis","enrollment":60},{"nctId":"NCT00629590","phase":"PHASE4","title":"Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-03","conditions":"Blepharitis","enrollment":20},{"nctId":"NCT01105624","phase":"PHASE4","title":"A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-03","conditions":"Contact Lens Dry Eye","enrollment":50},{"nctId":"NCT00237445","phase":"PHASE4","title":"Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days","status":"TERMINATED","sponsor":"Sanofi","startDate":"2005-11","conditions":"Pneumonia","enrollment":110},{"nctId":"NCT00983294","phase":"PHASE1","title":"Drug-Drug Interaction Study of Colchicine and Azithromycin","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2008-07","conditions":"Pharmacokinetics","enrollment":24},{"nctId":"NCT00649831","phase":"PHASE3","title":"A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2002-10","conditions":"Bronchitis, Chronic","enrollment":250},{"nctId":"NCT00356772","phase":"PHASE1","title":"Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers","status":"COMPLETED","sponsor":"Laboratoires Thea","startDate":"2003-02","conditions":"Eye Infections, Bacterial","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":17,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["AzaSite","Azithromycin ophthalmic 1%"],"phase":"marketed","status":"active","brandName":"AzaSite®","genericName":"AzaSite®","companyName":"Merck Sharp & Dohme LLC","companyId":"merck-sharp-dohme-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AzaSite is an azithromycin ophthalmic suspension that reduces bacterial load and inflammatory mediators in the eye to treat bacterial conjunctivitis and meibomian gland dysfunction. Used for Bacterial conjunctivitis, Meibomian gland dysfunction (dry eye disease).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}